Inaugural

Breast Cancer

US Focus Meeting 2025

calendar icon

Hilton Boston Back Bay, 40 Dalton St, Boston, MA 02115

calendar icon

April 25 - 26, 2025

For more information please contact:

cristina.anton@md-education.com

Dear Colleagues and Friends,

We are delighted to extend our warmest invitation to the Breast Cancer US Focus Meeting 2025, to be held at Hilton Boston Back Bay, 40 Dalton St, Boston, MA 02115 on April 25 - 26, 2025.

Centered around the theme “Updating Knowledge & Clinical Practice in 2025” this meeting provides pivotal collaboration aimed at advancing Breast Cancer research and patient treatment.

This meeting presents an opportunity for medical professionals to engage in the exchange of knowledge, expertise, and insights, as well as networking with leading experts. Engage in riveting presentations, participate in thought-provoking debates and roundtable discussions, and connect with peers at informal social gatherings.

Chairs of Breast Cancer Focus Meeting 2025:

Headshot of Chair: Virginia Kaklamani, MD

Virginia Kaklamani, MD

UT Health, San Antonio, TX

Headshot of Chair: Sara M. Tolaney, MD

Sara M. Tolaney, MD

Dana Farber Cancer Institute, Boston, MA

Thanks to Our Supporters

Agenda & Faculty

Friday, April 25, 2025 | Day 1

08:00 AM
Registration Opens

Session I: Treatment of Metastatic Disease


Moderated by:

Headshot of Sara Tolaney, MD

Sara Tolaney, MD

Dana Farber Cancer Institute, Boston, MA
09:00 AM
Metastatic HER2+ BC
Headshot of Ian Krop, MD

Ian Krop, MD

Yale School of Medicine, New Haven, CT
09:20 AM
Brain Mets
Headshot of Nancy Lin, MD

Nancy Lin, MD

Dana-Farber Cancer Institute, Boston, MA
09:40 AM
Treatment Approaches for Metastatic TNBC
Headshot of Priyanka Sharma, MD

Priyanka Sharma, MD

University of Kansas Medical Center, Kansas City, KS
10:00 AM
Panel Discussion
10:20 AM
Coffee Break & Networking

Session II: Novel Therapeutics


Moderated by:

Headshot of Virginia Kaklamani, MD

Virginia Kaklamani, MD

UT Health, San Antonio, TX
10:40 AM
Novel Cell Cycle Agents
Headshot of Antonio Giordano, MD

Antonio Giordano, MD

Dana Farber Cancer Institute, Boston, MA
11:00 AM
Future of Bispecifics
Headshot of Rita Nanda, MD

Rita Nanda, MD

The University of Chicago Medicine, IL
11:20 AM
Future of Oral SERDs
Headshot of Virginia Kaklamani, MD

Virginia Kaklamani, MD

UT Health, San Antonio, TX
11:40 AM
Novel Strategies for targeting PI3K
Headshot of Seth Wander, MD

Seth Wander, MD

Massachusetts General Hospital, Boston, MA
12:00 PM
Panel Discussion
12:20 PM
Lunch Break and Faculty Group Photo
01:10 PM
Industry Supported Independent Expert discussion.

Session III: Biomarker Assays


Moderated by:

Headshot of Virginia Kaklamani, MD

Virginia Kaklamani, MD

UT Health, San Antonio, TX
01:55 PM
The role of OFS and genomic assays in premenopausal
Headshot of Joseph Sparano, MD

Joseph Sparano, MD

Icahn School of Medicine at Mount Sinai, New York, NY
02:15 PM
Future of ctDNA
Headshot of Stefania Morganti, MD

Stefania Morganti, MD

Dana-Farber Cancer Institute, Boston, MA
02:35 PM
Panel Discussion
02:55 PM
Coffee Break & Networking

Session IV: Treatment of Early-Stage Disease


Moderated by:

Headshot of Sara M. Tolaney, MD

Sara M. Tolaney, MD

Dana Farber Cancer Institute, Boston, MA
03:15 PM
Optimization of Immunotherapy in Early-Stage Breast Cancer
Headshot of Heather McArthur, MD

Heather McArthur, MD

UT Southwestern Medical Center, Dallas, TX
03:35 PM
Treatment of Early Stage HER2+ Breast Cancer
Headshot of Mothaffar Rimawi, MD

Mothaffar Rimawi, MD

Baylor College of Medicine, Houston, TX
03:55 PM
Adjuvant cdk 4/6 inhibition: Who Needs Which Agent and For How Long?
Headshot of Erica Mayer, MD

Erica Mayer, MD

Dana-Farber Cancer Institute, Boston, MA
04:15 PM
Postmastectomy XRT: Who Needs it?
Headshot of Richard Zellars, MD

Richard Zellars, MD

Indiana University School of Medicine, Indianapolis, IN
04:35 PM
Panel Discussion
04:55 PM
Adjourn

Saturday, April 26, 2025 | Day 2

08:30 AM
Registration Opens

Session V: Treatment of Unique Patient Populations


Moderated by:

Headshot of Rachel Freedman, MD

Rachel Freedman, MD

Dana-Farber Cancer Institute, Boston, MA
09:00 AM
Optimal Assessment and Therapeutic Approaches for Older Patients with Breast Cancer
Headshot of Rachel Freedman, MD

Rachel Freedman, MD

Dana-Farber Cancer Institute, Boston, MA
09:20 AM
Treatment of Inflammatory Breast Cancer
Headshot of Filipa Lynce, MD

Filipa Lynce, MD

Dana Farber Cancer Institute, Boston, MA
09:40 AM
Panel Discussion
10:00 AM
Coffee Break & Networking

Session VI: ADCs and the Future


Moderated by:

Headshot of Sara M. Tolaney, MD

Sara M. Tolaney, MD

Dana Farber Cancer Institute, Boston, MA
10:20 AM
Role of ADCs
Headshot of Paolo Tarantino, MD

Paolo Tarantino, MD

Dana-Farber Cancer Institute, Boston, MA
10:40 AM
Sequencing of ADCs
Headshot of Paolo Tarantino, MD

Paolo Tarantino, MD

Dana-Farber Cancer Institute, Boston, MA
Headshot of Laura Huppert, MD

Laura Huppert, MD

UCSF Health, San Francisco, CA
11:00 AM
What we have learned from 30 Years of Performing SLN Biopsy
Headshot of Alastair Thompson, MD

Alastair Thompson, MD

Baylor College of Medicine, Houston, TX
11:20 AM
Panel Discussion
11:40 AM
Lunch Break and Faculty Group Photo
12:30 PM
Industry Supported Independent Expert discussion

Session VII: Disparities of Care


Moderated by:

Headshot of Virginia Kaklamani, MD

Virginia Kaklamani, MD

UT Health, San Antonio, TX
01:15 PM
Why Do Black Patients Have Higher Mortality from Breast Cancer
Headshot of Sonya Reid, MD

Sonya Reid, MD

Dana Farber Cancer Institute, Boston, MA
01:35 PM
Breast Cancer in Hispanics
Headshot of Marcela Canola, MD

Marcela Canola, MD

Dana Farber Cancer Institute, Boston, MA
01:55 PM
Panel Discussion
02:15 PM
Coffee Break & Networking

Session VIII: Academic Development


Moderated by:

Headshot of Sara M. Tolaney, MD

Sara M. Tolaney, MD

Dana Farber Cancer Institute, Boston, MA
02:35 PM
Lessons Learned from Leadership in Academia
Headshot of Angela DeMichele, MD

Angela DeMichele, MD

University of Pennsylvania, Philadelphia, PA
02:55 PM
How to Build a Survivorship Program
Headshot of Tara Sanft, MD

Tara Sanft, MD

Yale School of Medicine, New Haven, CT
03:15 PM
Panel Discussion
03:35 PM
Adjourn

Cristina Anton

Project Manager

How long has Cristina Anton been in the business?

Cristina Anton has been with MD Education since 2022

About Cristina Anton

I’m Romanian but have lived in the UK since 2015, serving as a Project Manager at MD Education's Wigan office since 2022. I have a diverse career background across various sectors, which has enriched my approach to project management. I’m dedicated and committed to excellence and I thrive on opportunities for personal and professional growth.